Debu Tripathy, MD is Professor of Medicine and Chair, Department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center. His clinical research focuses on the evaluation and development of novel therapeutics in breast cancer, specifically, growth factor receptor pathway targeting as well as biomarkers that predict sensitivity and resistance. He has also developed and conducted trial to assess integrative medicine including natural products for the treatment of breast cancer and symptom management. Dr. Tripathy has published numerous original laboratory and clinical research articles in the area of breast cancer and serves on several editorial boards, study sections, and societies as well as Editor-in-Chief of CURE Magazine and The American Journal of Hematology/ Oncology. He has previously served as the Presidents of the American Society of Breast Disease and the Society of Integrative Oncology.